Jul 15, 2022 / 02:40PM GMT
Michael Murray - Benzinga - Marketing Director
Our last presentation of All Access, we're going to keep moving because we did draw tight on time there. Full of information on that one, we're going to bring on Brady Granier, the President of BioCorRx trading on the OTC as BICX. Go ahead and get moving there. Brady, thanks for joining us. How are you?
Brady Granier - BioCorRx Inc. - President & Director
Thanks for having me. How are you? I'm good.
Michael Murray - Benzinga - Marketing Director
Always a pleasure. Yeah, Brady, we've had the opportunity to work with BioCor on a lot of different things over the last couple of months. Always a pleasure to speak with you guys, and we're excited to dive in here. But to get things started, give us an intro to BioCorRx and what the company does.
Brady Granier - BioCorRx Inc. - President & Director
BioCorRx, we've been in business around -- over a decade now. And we started out as an addiction -- a management company for an
BioCorRx Inc at Benzinga All Access Event Transcript
Feb 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers